Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1
Yihui Ma, Peiyi Xia, Zhengyang Wang, et al.
Neoplasia (2021) Vol. 23, Iss. 9, pp. 912-928
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy
Yazhen Wang, Zhou Yang, Lianyi Yang, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 26
Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response
Maurizio Callari, Martina Sola, Claudia Magrin, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling
Ping Zhu, Zhengxin Jin, Guiyu Kang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 21
Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
Jiaqi Liu, Chi Tim LEUNG, Luyun Liang, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3547-3547
Open Access | Times Cited: 20
PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
Kai Wang, Lili Yan, Xun Qiu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167236-167236
Closed Access | Times Cited: 4
A Pan-Cancer Analysis of Heat-Shock Protein 90 Beta1(HSP90B1) in Human Tumours
Yaxuan Wang, Xiaolin Wang
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1377-1377
Open Access | Times Cited: 19
circ-0000512 inhibits PD-L1 ubiquitination through sponging miR-622/CMTM6 axis to promote triple-negative breast cancer and immune escape
Li-Feng Dong, Fangfang Chen, Yang-Fan Fan, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e005461-e005461
Open Access | Times Cited: 10
Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
Peng Ding, Z. Ma, Yizeng Fan, et al.
Genes & Diseases (2022) Vol. 10, Iss. 3, pp. 848-863
Open Access | Times Cited: 16
MEN1 deficiency stabilizes PD‐L1 and promotes tumor immune evasion of lung cancer
Cuncun Zhang, Ning-Ning Sun, Qing-Ze Fei, et al.
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2515-2527
Open Access | Times Cited: 3
Menin in Cancer
Ariana D. Majer, Xianxin Hua, Bryson W. Katona
Genes (2024) Vol. 15, Iss. 9, pp. 1231-1231
Open Access | Times Cited: 3
The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells
Xiaoya Wan, Daiyuan Ma, Guanglin Song, et al.
Journal of Bioenergetics and Biomembranes (2024) Vol. 56, Iss. 3, pp. 323-332
Closed Access | Times Cited: 2
Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
Alice Capuz, Sylvain Osien, Mélodie‐Anne Karnoub, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 5
Expanding the ubiquitin code in pancreatic cancer
Wenyan Yang, Shiqun Wang, Shengqiang Tong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166884-166884
Closed Access | Times Cited: 5
Emerging role of deubiquitination modifications of programmed death-ligand 1 in cancer immunotherapy
Yao Jiang, Kai Hong, Yingchao Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, et al.
Advances in cancer research (2023), pp. 113-143
Closed Access | Times Cited: 3
Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma
Hanyao Guo, Sidi Zhang, Bo Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
Lucía Trilla‐Fuertes, Angelo Gámez‐Pozo, Guillermo Prado-Vázquez, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4407-4407
Open Access | Times Cited: 2
PDIA6, which is regulated by TRPM2-AS/miR-424-5p axis, promotes endometrial cancer progression via TGF-beta pathway
Pengling Wang, Tianli Zhang, Nan Jiang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 2
Ubiquitin signaling in pancreatic ductal adenocarcinoma
Shengnan Lv, Jian Zhang, Xinyu Peng, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2
PDIA6 promotes immune escape of head and neck squamous cell carcinoma by regulating TIGIT/CD155 axis
Weiwei Jiang, Ji Wang, Kai Song, et al.
Research Square (Research Square) (2024)
Open Access
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease
Susan Yeyeodu, Donia Hanafi, Kenisha Webb, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access
Direct estimation and inference of higher-level correlations from lower-level measurements with applications in gene-pathway and proteomics studies
Yue Wang, Haoran Shi
Biostatistics (2024)
Open Access
Dual roles for a tick protein disulfide isomerase during the life cycle of the Lyme disease agent
Xiaotian Tang, Yingjun Cui, Ushuu Namarra, et al.
mBio (2024)
Open Access
PDIA6 promotes the progression of ESCC via AKT1/mTOR signal pathway by forming disulfide-dependent TRAF4
Kangdong Liu, Yingying Chen, Xiaoyu Li, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1 - Next Page

Scroll to top